Press Releases

Tue Sep 16 2025 03:38:00 GMT+0000 (Coordinated Universal Time)

Bioneex Integrates GATC Health’s AI Capabilities to Enhance Drug Risk Prediction on Its Platform

Collaboration brings validated predictive analytics to accelerate biotech deal making and de-risk investment decisions

Fri Aug 29 2025 03:35:00 GMT+0000 (Coordinated Universal Time)

Bioneex's AI Agent Helped Stanford Founded Emerging Biotech Identify Novel Asset

Bioneex's AI-powered platform accelerates therapeutic asset search and evaluation, enabling biopharma companies and venture capital firms to identify and assess high-potential opportunities faster than ever before.

Tue Feb 27 2024 02:54:14 GMT+0000 (Coordinated Universal Time)

Bioneex Raises $0.5 Million Seed Round to Expand its Biopharma R&D Business Development Platform

Investment Led by Global Biopharma Executives as Company Adds Industry Expertise to its Advisory Board

Mon Jan 30 2023 08:29:57 GMT+0000 (Coordinated Universal Time)

Bioneex and TVM Capital Life Science Launch Global Forum Bringing Together Biotech Companies and Venture Capital Firms

Partnership Increases Investment and Drug Candidates Licensing and Partnership Opportunities for Biotech and Biopharma Companies

Tue Oct 11 2022 11:04:34 GMT+0000 (Coordinated Universal Time)

Former Pfizer Executive Dr. Andreas Penk Joins Bioneex Advisory Board

Bioneex expands senior advisory team to support expansion into global oncology space and addition of Chinese biopharma innovation to its exchange platform

Tue Mar 22 2022 12:28:00 GMT+0000 (Coordinated Universal Time)

Bioneex and ALSA Ventures Partner to Provide Biotech Firms a New Way to Drug Candidate Out-Licensing and Acquiring Investment

Biotech, biopharma companies, and research institutions by listing their drug candidates on Bioneex connect directly with potential licensing and co-development partners as well as investors